BlackRock »

Arbutus Biopharma shares owned by BlackRock

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by BlackRock from 13F filings

Historical chart of BlackRock investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by BlackRock consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by BlackRock

Quarter filed Position value Share count Share price at filing
2024-09-30 $47M 12M 3.85

More positions owned by BlackRock

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Eli Lilly & Co. (LLY)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
UnitedHealth (UNH)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core S&p500 Etf (IVV)
Visa Com Cl A (V)

View all positions for BlackRock

Top funds holding Arbutus Biopharma

Morgan Stanley
Whitefort Capital Management
BlackRock
BlackRock
Two Seas Capital
Vanguard Group
Geode Capital Management
State Street Corporation
BlackBarn Capital Partners
Rubric Capital Management
Squarepoint Ops
Advisor Group Holdings
Northern Trust
Charles Schwab Investment Management
Hudson Bay Capital Management

View all funds holding Arbutus Biopharma